Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Proxalutamide

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kintor Pharma and Etana's Collaboration on Pruxelutamide's COVID-19 Project
    Kintor Pharma and Etana's Collaboration on Pruxelutamide's COVID-19 Project

    14 Jun 2022

    // ASIAONE

    https://www.asiaone.com/business/kintor-pharma-and-etanas-collaboration-pruxelutamides-covid-19-project-awarded-belt-and

    ASIAONE
    14 Jun 2022
    Share Share
    Kintor's Proxalutamide Showed Reduction in Hospitalization/Mortality in COVID-19
    Kintor's Proxalutamide Showed Reduction in Hospitalization/Mortality in COVID-19

    05 Apr 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/kintor-pharmas-proxalutamide-demonstrated-reduction-in-hospitalizationmortality-for-patients-with-mild-to-moderate-covid-19-in-phase-iii-mrct-study-301518525.html

    PRNEWSWIRE
    05 Apr 2022
    Share Share
    Kintor Pharma Begins Dosing in Phase III Clinical Trial of Proxalutamide
    Kintor Pharma Begins Dosing in Phase III Clinical Trial of Proxalutamide

    11 Feb 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/kintor-pharma-announces-first-patient-dosing-in-china-in-phase-iii-clinical-trial-of-proxalutamide-for-the-treatment-of-covid-19-outpatients-301480612.html

    PRNEWSWIRE
    11 Feb 2022
    Share Share
    Kintor's interim analysis of COVID treatment trial misses statistical criteria
    Kintor's interim analysis of COVID treatment trial misses statistical criteria

    28 Dec 2021

    // REUTERS

    https://www.reuters.com/article/us-health-coronavirus-kintor-pharm/chinas-kintor-says-interim-analysis-of-covid-treatment-trial-misses-statistical-criteria-idUSKBN2J60NV

    REUTERS
    28 Dec 2021
    Share Share
    Kintor begins patient dosing in phase 3 of proxalutamide for Covid-19 patients
    Kintor begins patient dosing in phase 3 of proxalutamide for Covid-19 patients

    05 Oct 2021

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=143009&sid=2

    PHARMABIZ
    05 Oct 2021
    Share Share
    Kintor begins patient dosing in phase 3 of proxalutamide for Covid-19 patients
    Kintor begins patient dosing in phase 3 of proxalutamide for Covid-19 patients

    05 Oct 2021

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=143009&sid=2

    PHARMABIZ
    05 Oct 2021
    Share Share